Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 183 entries
View as:

Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06644404 Org: User:
Start: 10/26/24 End: 04/01/25 Due: 04/01/26

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

Phase: N/A Priority: Normal
NCT ID: NCT03736369 Org: User:
Start: 12/13/18 End: 08/07/19 Due: 08/07/20

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03573622 Org: User:
Start: 05/31/18 End: 10/12/18 Due: 10/12/19

Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04819932 Org: User:
Start: 03/13/21 End: 04/02/21 Due: 04/02/22

Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

Phase: N/A Priority: Normal
NCT ID: NCT05207176 Org: User:
Start: 02/14/22 End: 08/31/22 Due: 08/31/23

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03512808 Org: User:
Start: 06/01/17 End: 07/31/17 Due: 07/31/18

Efficacy and Safety of DWC202404 and DWC202314 in Patients with Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06682000 Org: User:
Start: 01/01/25 End: 12/31/26 Due: 12/31/27

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT04784910 Org: User:
Start: 05/21/21 End: 12/11/23 Due: 12/11/24

To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04767815 Org: User:
Start: 03/22/21 End: 06/04/21 Due: 06/04/22

Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)

Phase: N/A Priority: Normal
NCT ID: NCT04926623 Org: User:
Start: 06/17/21 End: 04/04/23 Due: 04/04/24

Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01629199 Org: User:
Start: 10/31/10 End: 09/30/12 Due: 09/30/13

Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT05072938 Org: User:
Start: 09/30/21 End: 12/15/22 Due: 12/15/23

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05889143 Org: User:
Start: 05/24/23 End: 06/30/25 Due: 06/30/26

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

Phase: N/A Priority: Normal
NCT ID: NCT03184324 Org: User:
Start: 08/28/17 End: 04/18/18 Due: 04/18/19

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02693522 Org: User:
Start: 10/31/03 End: 12/31/04 Due: 12/31/05

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01635686 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04328766 Org: User:
Start: 09/06/20 End: 11/21/20 Due: 11/21/21

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Phase: N/A Priority: Normal
NCT ID: NCT04120753 Org: User:
Start: 08/26/19 End: 07/06/21 Due: 07/06/22

Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05660135 Org: User:
Start: 06/20/22 End: 06/30/25 Due: 06/30/26

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04888715 Org: User:
Start: 07/23/21 End: 08/18/21 Due: 08/18/22

Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

Phase: N/A Priority: Normal
NCT ID: NCT02882893 Org: User:
Start: 08/31/16 End: 04/30/17 Due: 04/30/18

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

Phase: N/A Priority: Normal
NCT ID: NCT02069717 Org: User:
Start: 10/31/13 End: 09/30/14 Due: 09/30/15

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Phase: N/A Priority: Normal
NCT ID: NCT04772443 Org: User:
Start: 02/28/21 End: 12/31/22 Due: 12/31/23

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04003441 Org: User:
Start: 06/30/19 End: 08/31/19 Due: 08/31/20

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05304845 Org: User:
Start: 03/21/22 End: 05/22/22 Due: 05/22/23